Eitan Kyiet - Kamada Vice President - Business Development
| KMDA Stock | ILA 2,121 23.00 1.10% |
President
Mr. Eitan Kyiet is Vice President Business Development of the Company. Prior to joining Kamada, Mr. Kyiet served as Chief Operating Officer of PolyPid, a clinicalstage emerging biopharmaceutical company. Earlier in his career, he was Director, Worldwide Supply Chain, at Biosense Webster, a leader in the diagnosis and treatment of heart arrhythmias. Prior to this, Mr. Kyiet served as Director, Global Strategic Operations and Alliances, for Lumenis, Ltd., a leading medical equipment and laser device manufacturer. He began his career practicing corporate law, both as inhouse counsel and as a Partner at Amit, Pollak, Matalon Co. Mr. Kyiet has over 20 years of experience in business development, strategic operations and corporate law, with a significant portion of his career spent in the life sciences industry. He will lead Kamada business development and strategic commercial activities, with a focus on advancing market opportunities for the Company products since 2018.
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | (972) 8 9406472 |
| Web | www.kamada.com |
Kamada Management Efficiency
Kamada's management efficiency ratios could be used to measure how well Kamada manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Akhtar Ashfaq | Opko Health | N/A | |
| Zmira ShternfeldLavie | Tower Semiconductor | 52 | |
| Avi Strum | Tower Semiconductor | 61 | |
| Itzhak Edrei | Tower Semiconductor | 58 | |
| Gary Saunders | Tower Semiconductor | 54 | |
| Yossi Netzer | Tower Semiconductor | 59 | |
| David Stark | Teva Pharmaceutical Industries | 54 | |
| Yehuda Vered | Elbit Systems | 65 | |
| Edgar Maimon | Elbit Systems | 64 | |
| Ran Kril | Elbit Systems | 52 | |
| Yuval Ramon | Elbit Systems | 57 | |
| Sven Dethlefs | Teva Pharmaceutical Industries | 54 | |
| Richard Daniell | Teva Pharmaceutical Industries | 52 | |
| Yoram Shmuely | Elbit Systems | 62 | |
| Elad Aharonson | Elbit Systems | 45 | |
| Eliyahu Kalif | Teva Pharmaceutical Industries | 50 | |
| Marco Racanelli | Tower Semiconductor | 56 | |
| Nati Somekh | Tower Semiconductor | 48 | |
| Kevin Mannix | Teva Pharmaceutical Industries | N/A | |
| Shelly Gordon | Elbit Systems | 58 | |
| Brendan OGrady | Teva Pharmaceutical Industries | 52 | |
Management Performance
| Return On Equity | -0.058 | |||
| Return On Asset | -0.0023 |
Kamada Leadership Team
Elected by the shareholders, the Kamada's board of directors comprises two types of representatives: Kamada inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kamada. The board's role is to monitor Kamada's management team and ensure that shareholders' interests are well served. Kamada's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kamada's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pnina Strauss, Vice President - Inhalation programs & IP | ||
| Itzhak Krinsky, Director | ||
| Lilach Topilsky, Chairman of the Board | ||
| Ari Shamiss, Director | ||
| Barak Bashari, Vice President - Operations | ||
| Eran Schenker, Vice President - Medical Director | ||
| Tuvia Shoham, Independent Director | ||
| Eran Nir, Chief Officer | ||
| Hanni Neheman, VP Sales | ||
| Michal Stein, Vice President and Medical Director for Immunology | ||
| Ariella Raban, VP HR | ||
| Shani Dotan, Vice President of Human Resources | ||
| Yael Brenner, Vice President - Quality | ||
| Abraham Havron, Independent Director | ||
| Ruth Wolfson, Senior Vice President - Scientific Affairs | ||
| Shmuel Rubinstein, Director | ||
| Naveh Tov, Vice President-Clinical Development and Medical Director for Pulmonary Diseases | ||
| Jon Knight, VP Operations | ||
| Michael Berelowitz, Director | ||
| David Tsur, Co-Founder and Deputy Executive Chairman | ||
| Orit Pinchuk, Vice President - Regulatory Affairs and Quality R&D | ||
| Leon Recanati, Chairman of the Board | ||
| Jonathan Hahn, Director | ||
| Gwen Melincoff, Director | ||
| Chaime Orlev, Chief Financial Officer | ||
| Michal Ayalon, Vice President - Research & Development | ||
| Yifat Esq, Gen Legal | ||
| Amir London, Chief Executive Officer | ||
| Estery GilozRan, Independent Director | ||
| Eitan Kyiet, Vice President - Business Development |
Kamada Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kamada a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.058 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.01) % | |||
| Current Valuation | 636.38 M | |||
| Shares Outstanding | 44.8 M | |||
| Shares Owned By Insiders | 18.50 % | |||
| Shares Owned By Institutions | 32.04 % | |||
| Price To Book | 1.13 X | |||
| Price To Sales | 5.37 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Kamada Stock
When determining whether Kamada offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kamada's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kamada Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kamada Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kamada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.